NEW YORK (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying Mylan for $40 billion, saying it was a better deal than the smaller rival's offer to buy Perrigo Co.
The bid comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.
19:39 $1M '100 percent Swiss Made' watch made of real Swiss cheese9
21:52 Netflix nears 94 million subscribers 10 years after streaming launch17
16:50 Goldman Sachs, Citigroup earnings confirm Trump effect on banks18
18:21 Mark Zuckerberg takes the stand in $2 billion lawsuit claiming Oculus theft8